despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
https://grassfed.us/Luing-father-of-Coffey-from-Bikaner . a little under 60% of these encounters resulted in hospitalization and of these, about 13% required intensive care.
.